Investment Rating - The investment rating for the company is "Accumulate" [5] Core Views - The company continues to maintain over 30% revenue growth, with a significant increase in expenses leading to a temporary adjustment in performance [1] - The company focuses on skin science and biological research for the development, design, production, and sales of various cosmetics, aiming to meet diverse consumer needs through differentiated brand positioning [4] - The company emphasizes a long-term strategy driven by technology, aiming to build a world-class competitive beauty enterprise [9] Financial Summary - Revenue for 2023 is projected at 2,226 million yuan, with a year-on-year growth rate of 28.5%. By 2027, revenue is expected to reach 5,726 million yuan, with a growth rate of 20.8% [1] - Net profit attributable to the parent company is forecasted to be 259 million yuan in 2023, growing to 636 million yuan by 2027, with a growth rate of 20.9% [1] - The company's overall gross margin is stable at 74.60%, with sales expenses increasing by 39.31% due to rising online traffic costs and ongoing brand building efforts [2] Brand and Market Positioning - The Marubi brand continues to solidify its position in eye care, while the PL brand focuses on high-quality, minimalist makeup, enhancing brand value [3] - The company is committed to internal development, enhancing R&D, product innovation, and digital empowerment to improve operational efficiency [3] Stock Information - As of September 2, 2025, the closing price is 39.53 yuan, with a total market capitalization of 15,851.53 million yuan [5]

Market Overview - The cosmetics sector experienced a decline of 1.93% on September 3, with Jiaheng Jiahua leading the drop [1] - The Shanghai Composite Index closed at 3813.56, down 1.16%, while the Shenzhen Component Index closed at 12472.0, down 0.65% [1] Individual Stock Performance - Bawei Co. (837023) saw an increase of 2.86%, closing at 20.17 with a trading volume of 70,000 shares and a turnover of 139 million yuan [1] - Lafang Jiahua (603630) increased by 2.46%, closing at 28.35 with a trading volume of 171,800 shares and a turnover of 496 million yuan [1] - Jiaheng Jiahua (300955) experienced the largest decline of 8.73%, closing at 32.09 with a trading volume of 141,300 shares and a turnover of 475 million yuan [2] - Other notable declines include Huaye Fragrance (300886) down 6.05% and Jincheng New Materials (300849) down 3.78% [2] Capital Flow Analysis - The cosmetics sector saw a net outflow of 176 million yuan from institutional investors, while retail investors contributed a net inflow of 95.35 million yuan [2] - The main capital inflow and outflow for individual stocks showed that Lafang Jiahua had a net inflow of 28.51 million yuan from institutional investors, while Jiaheng Jiahua had a net outflow of 7.93 million yuan [3] - The overall trend indicates a mixed sentiment among retail and institutional investors, with retail investors showing some interest despite the overall sector decline [2][3]

Market Overview - The Shanghai Composite Index closed at 3820.98 points, below the five-day moving average, with a decline of 0.96% [1] - The total trading volume of A-shares reached 1,472.176 billion yuan [1] Stocks Performance - A total of 141 A-shares broke through the five-day moving average today [1] - Stocks with significant deviation rates include: - Hailianxun (300277) with a deviation rate of 14.15% and a daily increase of 20.03% [1] - Shoukai Co., Ltd. (600376) with a deviation rate of 7.01% and a daily increase of 9.85% [1] - Zhongchen Technology (603275) with a deviation rate of 6.97% and a daily increase of 9.99% [1] - Other notable stocks with smaller deviation rates include: - Marubi Biotechnology (002067) with a deviation rate of 6.55% and a daily increase of 10.00% [1] - Hanzhong Precision Machinery (002158) with a deviation rate of 6.30% and a daily increase of 10.00% [1] Additional Stocks Data - Other stocks with notable performance include: - Baolid (300905) with a daily increase of 10.65% and a deviation rate of 6.05% [1] - Jingrui Materials (300655) with a daily increase of 8.42% and a deviation rate of 5.69% [1] - Stocks with lower performance but still above the five-day moving average include: - Shankai Intelligent (300897) with a daily increase of 6.02% and a deviation rate of 2.99% [2] - Jianghuai Micro (603078) with a daily increase of 6.76% and a deviation rate of 2.76% [2]

Meeting Information - The first extraordinary general meeting of shareholders for 2025 is scheduled for September 19, 2025, at 15:00 [1] - The meeting will be held at Marubi Building, 11th Floor, No. 69, Xinguang East Road, Haizhu District, Guangzhou [1] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's voting system [1] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange's online voting system from 9:15 to 15:00 on the day of the meeting [1][2] - Shareholders holding multiple accounts can aggregate their voting rights across all accounts [3][4] - The first voting result will be considered valid if the same voting right is exercised multiple times [4] Attendance Requirements - Shareholders must register to attend the meeting, providing necessary identification documents [5][6] - Registration will be open on September 17, 2025, from 9:30 to 11:30 and 14:00 to 16:30 [6] - The meeting is expected to last half a day, with attendees responsible for their own travel and accommodation expenses [6] Contact Information - For inquiries, contact Cheng Di or Tan Yunxin at 020-6637 8685 or via email at securities@marubi.cn [6]

Summary of Key Points Core Viewpoint - Guangdong Marubi Biotechnology Co., Ltd. has recently relocated its office to a new address, which is communicated to investors to ensure transparency and maintain contact. Company Information - The company has changed its office address from "Tianhe District, Zhujiang New Town, Xian Village Road, Guangzhou" to "No. 69, Xin Gang East Road, Haizhu District, Guangzhou" [1] - The new postal code for the office is 510308, replacing the previous code 510623 [1] - Other contact information, including investor phone number and email, remains unchanged [1]

Group 1 - The company Marubi Biotechnology has recently announced its relocation to a new office address [2] - The new office is located at 11th Floor, Marubi Building, No. 69, Xinguang East Road, Haizhu District, Guangzhou, with postal code 510308 [2]

Group 1 - The company, Marubi Biotechnology, announced that it will hold its first extraordinary general meeting of shareholders for 2025 on September 19, 2025 [2] - The agenda for the meeting includes the review of the company's profit distribution plan for the first half of 2025 [2]

Market Overview - The cosmetics sector experienced a decline of 0.97% on September 2, with Huaye Fragrance leading the drop [1] - The Shanghai Composite Index closed at 3858.13, down 0.45%, while the Shenzhen Component Index closed at 12553.84, down 2.14% [1] Individual Stock Performance - Jiahen Jiahua (300955) saw a significant increase of 7.16%, closing at 35.16 with a trading volume of 127,400 shares and a turnover of 437 million yuan [1] - Other notable gainers included Bawi Co. (837023) with a 3.87% increase and Lafang Jiahua (603630) with a 2.60% increase [1] - Conversely, Huaye Fragrance (300886) led the declines with a drop of 4.05%, closing at 31.55 [2] - The overall performance of the cosmetics sector showed mixed results, with several stocks experiencing declines [2] Capital Flow Analysis - The cosmetics sector saw a net outflow of 216 million yuan from institutional investors, while retail investors contributed a net inflow of 210 million yuan [2] - The table of capital flow indicates that Lafang Jiahua had a net inflow of 49.77 million yuan from institutional investors, despite a net outflow from retail investors [3] - Other companies like Jinxing New Materials (300849) and Shanghai Jahwa (600315) also experienced varying degrees of net inflows and outflows from different investor categories [3]

办公地址：广州市海珠区新港东路 69 号丸美大厦 11 楼 邮政编码：510308 证券代码：603983 证券简称：丸美生物 公告编号：2025-024 广东丸美生物技术股份有限公司 关于变更办公地址的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 广东丸美生物技术股份有限公司（以下简称"公司"）已于近日搬迁至新办 公地址，具体情况如下： | 变更事项 | 变更前 | | | | | 变更后 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 办公地址 | 广州市天河区珠江新城冼村路 | | | | 广州市海珠区新港东路 | | 69 号丸美 | | | 11 | 号保利威座大厦南塔 | 6 楼 | 大厦 11 | 楼 | | | | 邮政编码 | | 510623 | | | | 510308 | | 除上述变更内容外，公司投资者联系电话、电子邮箱等其他联系方式均保持 不变，具体如下： 投资者联系电话：020-66378685 传真号码：020-663 ...

证券代码：603983 证券简称：丸美生物 公告编号：2025-025 广东丸美生物技术股份有限公司 关于召开2025年第一次临时股东大会的通知 股东大会召开日期：2025年9月19日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 (一) 股东大会类型和届次 2025年第一次临时股东大会 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票 相结合的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 9 月 19 日 15 点 00 分 召开地点：广州市海珠区新港东路 69 号丸美大厦 11 楼会议室 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证券交易所上市公司自律监管指引第 1 号-规范运作》等有关 规定执行。 (七) 涉及公开征集股东投票权 无。 二、 会议审议事项 本次股东大会审议议案及投票股东类型 ...